tiprankstipranks
Trending News
More News >
Grand Pharmaceutical Group Limited (HK:0512)
:0512
Hong Kong Market
Advertisement

Grand Pharmaceutical Group Limited (0512) Ratios

Compare
4 Followers

Grand Pharmaceutical Group Limited Ratios

HK:0512's free cash flow for Q4 2024 was HK$0.56. For the 2024 fiscal year, HK:0512's free cash flow was decreased by HK$ and operating cash flow was HK$0.19. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.22 1.22 1.07 1.22 1.24
Quick Ratio
1.01 0.98 0.86 1.02 1.01
Cash Ratio
0.20 0.23 0.22 0.32 0.43
Solvency Ratio
0.35 0.31 0.30 0.36 0.37
Operating Cash Flow Ratio
0.26 0.42 0.30 0.38 0.41
Short-Term Operating Cash Flow Coverage
0.55 1.05 0.59 1.00 1.13
Net Current Asset Value
HK$ -440.31MHK$ -228.66MHK$ -1.28BHK$ -835.58MHK$ -321.18M
Leverage Ratios
Debt-to-Assets Ratio
0.18 0.15 0.20 0.17 0.14
Debt-to-Equity Ratio
0.27 0.22 0.32 0.27 0.21
Debt-to-Capital Ratio
0.21 0.18 0.24 0.21 0.18
Long-Term Debt-to-Capital Ratio
0.07 0.06 0.08 0.10 0.07
Financial Leverage Ratio
1.52 1.49 1.58 1.57 1.51
Debt Service Coverage Ratio
0.94 1.00 0.79 1.23 1.26
Interest Coverage Ratio
11.74 12.98 18.31 21.71 13.08
Debt to Market Cap
0.13 0.24 0.27 0.16 0.10
Interest Debt Per Share
1.32 1.03 1.30 1.05 0.73
Net Debt to EBITDA
0.89 0.70 0.98 0.61 0.22
Profitability Margins
Gross Profit Margin
57.86%61.96%62.24%61.03%63.52%
EBIT Margin
25.63%24.21%27.76%33.48%34.46%
EBITDA Margin
29.96%28.17%32.35%36.11%38.00%
Operating Profit Margin
18.17%25.29%26.33%23.48%23.76%
Pretax Profit Margin
23.22%22.26%26.78%31.08%31.66%
Net Profit Margin
21.20%17.85%21.75%27.94%28.22%
Continuous Operations Profit Margin
19.90%18.24%21.94%27.97%28.04%
Net Income Per EBT
91.30%80.20%81.21%89.92%89.12%
EBT Per EBIT
127.77%88.02%101.71%132.37%133.28%
Return on Assets (ROA)
9.88%8.35%9.30%11.41%10.55%
Return on Equity (ROE)
15.34%12.40%14.71%17.94%15.95%
Return on Capital Employed (ROCE)
11.49%15.87%15.82%13.03%11.90%
Return on Invested Capital (ROIC)
8.41%11.25%10.99%9.83%9.05%
Return on Tangible Assets
11.66%9.27%10.56%12.74%11.88%
Earnings Yield
7.55%13.40%12.76%10.48%7.56%
Efficiency Ratios
Receivables Turnover
4.18 0.00 4.33 4.00 3.70
Payables Turnover
4.03 3.01 4.14 4.56 3.50
Inventory Turnover
3.58 2.88 2.69 3.00 2.43
Fixed Asset Turnover
3.04 2.64 2.43 2.26 1.86
Asset Turnover
0.47 0.47 0.43 0.41 0.37
Working Capital Turnover Ratio
7.07 12.26 11.63 7.72 10.22
Cash Conversion Cycle
98.74 5.31 131.51 132.93 144.71
Days of Sales Outstanding
87.34 0.00 84.24 91.25 98.60
Days of Inventory Outstanding
101.96 126.54 135.50 121.69 150.44
Days of Payables Outstanding
90.56 121.23 88.23 80.01 104.33
Operating Cycle
189.30 126.54 219.74 212.94 249.04
Cash Flow Ratios
Operating Cash Flow Per Share
0.49 0.69 0.54 0.60 0.52
Free Cash Flow Per Share
0.33 0.55 0.07 0.42 0.38
CapEx Per Share
0.17 0.14 0.47 0.18 0.14
Free Cash Flow to Operating Cash Flow
0.66 0.79 0.13 0.70 0.74
Dividend Paid and CapEx Coverage Ratio
1.16 2.44 0.93 2.09 2.24
Capital Expenditure Coverage Ratio
2.97 4.87 1.15 3.38 3.80
Operating Cash Flow Coverage Ratio
0.39 0.71 0.43 0.58 0.74
Operating Cash Flow to Sales Ratio
0.15 0.23 0.20 0.25 0.28
Free Cash Flow Yield
3.50%13.74%1.51%6.52%5.52%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
13.25 7.46 7.84 9.54 13.22
Price-to-Sales (P/S) Ratio
2.81 1.33 1.70 2.67 3.73
Price-to-Book (P/B) Ratio
1.99 0.93 1.15 1.71 2.11
Price-to-Free Cash Flow (P/FCF) Ratio
28.60 7.28 66.29 15.33 18.11
Price-to-Operating Cash Flow Ratio
18.97 5.79 8.50 10.80 13.35
Price-to-Earnings Growth (PEG) Ratio
4.51 -0.88 -0.59 0.31 0.27
Price-to-Fair Value
1.99 0.93 1.15 1.71 2.11
Enterprise Value Multiple
10.27 5.43 6.25 7.99 10.03
Enterprise Value
35.81B 16.10B 19.32B 24.81B 24.22B
EV to EBITDA
10.27 5.43 6.25 7.99 10.03
EV to Sales
3.08 1.53 2.02 2.89 3.81
EV to Free Cash Flow
31.31 8.35 78.62 16.59 18.51
EV to Operating Cash Flow
20.77 6.64 10.08 11.69 13.64
Tangible Book Value Per Share
3.63 3.71 3.25 3.17 2.74
Shareholders’ Equity Per Share
4.70 4.32 3.99 3.77 3.26
Tax and Other Ratios
Effective Tax Rate
0.14 0.19 0.16 0.14 0.15
Revenue Per Share
3.33 3.00 2.70 2.42 1.84
Net Income Per Share
0.70 0.54 0.59 0.68 0.52
Tax Burden
0.91 0.80 0.81 0.90 0.89
Interest Burden
0.91 0.92 0.96 0.93 0.92
Research & Development to Revenue
0.05 0.05 0.06 0.04 0.03
SG&A to Revenue
0.00 0.12 0.09 0.11 0.11
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
0.70 1.29 0.92 0.88 0.99
Currency in HKD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis